Genpact Limited (NYSE:G) declared a quarterly dividend on Wednesday, November 22nd, NASDAQ reports. Investors of record on Friday, December 8th will be given a dividend of 0.06 per share by the business services provider on Wednesday, December 20th. This represents a $0.24 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Thursday, December 7th.
Genpact has a dividend payout ratio of 16.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Genpact to earn $1.61 per share next year, which means the company should continue to be able to cover its $0.24 annual dividend with an expected future payout ratio of 14.9%.
Genpact (G) traded down $0.09 during midday trading on Wednesday, reaching $32.16. The company had a trading volume of 1,607,600 shares, compared to its average volume of 1,039,239. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.77. Genpact has a one year low of $23.34 and a one year high of $32.51. The stock has a market cap of $6,225.62, a PE ratio of 20.94, a PEG ratio of 2.20 and a beta of 0.58.
In other news, insider Mohit Thukral sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $32.25, for a total transaction of $806,250.00. Following the transaction, the insider now owns 85,305 shares of the company’s stock, valued at approximately $2,751,086.25. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Piyush Mehta sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $32.00, for a total value of $400,000.00. Following the transaction, the senior vice president now directly owns 77,944 shares in the company, valued at approximately $2,494,208. The disclosure for this sale can be found here. Insiders have sold a total of 1,575,051 shares of company stock worth $47,739,747 over the last ninety days. Insiders own 1.41% of the company’s stock.
An institutional investor recently raised its position in Genpact stock. The Manufacturers Life Insurance Company increased its stake in shares of Genpact Limited (NYSE:G) by 7.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 6,508 shares of the business services provider’s stock after purchasing an additional 455 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 at the end of the most recent quarter. Institutional investors own 91.16% of the company’s stock.
G has been the topic of a number of research analyst reports. Zacks Investment Research cut Genpact from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Cantor Fitzgerald reissued a “buy” rating and issued a $32.00 price target on shares of Genpact in a report on Wednesday, September 13th. Robert W. Baird reissued a “buy” rating and issued a $34.00 price target on shares of Genpact in a report on Monday, September 25th. BMO Capital Markets reissued a “hold” rating on shares of Genpact in a report on Friday, October 6th. Finally, SunTrust Banks reissued a “buy” rating and issued a $34.00 price target on shares of Genpact in a report on Monday, October 9th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $33.38.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
What are top analysts saying about Genpact Limited? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Genpact Limited and related companies.